Shufersal Ltd (TASE:SAE) notified the Tel Aviv Stock Exchange it was in advanced talks with New-Pharm Drugstores Ltd. and for the first time it revealed the value of New-Pharm, with the talks being conducted in the NIS 115 million and NIS 135 million price range. Shufersal added that its board of directors has yet to approve any deal nor has any approval yet been received from the Israel Antitrust Authority. It is therefore by no means certain that any deal will eventually be signed.